natgillin/translations-raw huggingface dataset:
Lack of body water (dehydration) with thirst or headache;
pomanjkanje vode v telesu (dehidracija), ki se kaže z žejo ali glavobolom;
lack of co-ordination; spinning sensation (vertigo); balance problems; problems walking
pomanjkanje koordinacije, občutek vrtenja (vrtoglavica), težave z ravnotežjem, težave s hojo,
lack of control over passing stools (faecal incontinence)
pomanjkanje nadzora uhajanja blata (fekalna inkontinenca)
Lack of early virologic response by Treatment week 12 (detectable HCV-RNA with a < 2 log10 reduction from baseline) was a criterion for discontinuation of treatment.
Kriterij za ukinitev zdravljenja je bila odsotnost zgodnjega virološkega odziva do 12. tedna zdravljenja (merljiva koncentracija HCV-RNA z zmanjšanjem za < 2 log10 glede na začetno vrednost).
Lack of effect or decreased response to treatment.
Pomanjkljiv učinek ali zmanjšan odziv na zdravljenje.
lack of emotion
motnje čustvovanja
lack of energy
pomanjkanje energije
lack of energy (fatigue)
pomanjkanje energije (utrujenost)
Lack of energy (lethargy)
pomanjkanje energije (letargija),
lack of energy blocked nose.
pomanjkanje energije, zamašen nos.
Lack of energy or feeling weak or tired
pomanjkanje energije, občutek šibkosti ali utrujenosti
lack of energy or weakness (asthenia),
pomanjkanje energije ali šibkost (astenija),
lack of energy,
pomanjkanje energije,
Lack of energy, feeling weak
pomanjkanje energije, občutek šibkosti
Lack of energy, feeling weak or tired
pomanjkanje energije, občutek šibkosti ali utrujenosti
lack of energy; irritation at infusion site; feeling unwell; chest discomfort; accumulation of fluid in the lower legs; pain; fever; skin flushing of upper body abnormal blood clotting tests
pomanjkanje energije, draženje na mestu infuzije, slabo počutje, neprijeten občutek v prsnem košu, nabiranje tekočine v spodnjem predelu nog, bolečine, vročina, pordelost kože v zgornjem predelu telesa nenormalni rezultati testov koagulacije krvi
lack of functioning of the testes;
zmanjšano delovanje mod;
lack of functioning of the testes;
zmanjšano delovanje testisov;
Lack of interchangeability between botulinum toxin products
Nezamenljivost zdravil, ki vsebujejo botulinski toksin
Lack of interest, feeling confused, increased sex drive, panic attack, loss of memory, problems sleeping.
pomanjkanje zanimanja, občutek zmedenosti, zvišan libido, napad panike, izguba spomina, težave s spanjem
Lack of long-term safety data
Pomanjkanje podatkov o varnosti pri dolgoročni uporabi zdravila
lack of oxygen
pomanjkanje kisika
Lack of pharmacokinetics interaction bounds 50-200%.
Območje 50-200 %, znotraj katerega ni farmakokinetičnih interakcij.
Lack of pharmacokinetics interaction bounds 70-143%.
Območje 70–143 %, znotraj katerega ni farmakokinetičnih interakcij
Lack of red blood cells (anaemia)
pomanjkanje eritrocitov (anemija)
lack of sense of touch
izguba občutka dotika,
Lack of sleep
pomanjkanje spanja
Lack of urine.
pomanjkanje urina
lack of white blood cells associated with fever and infection
pomanjkanje belih krvnih celic, povezano z zvišano telesno temperaturo in okužbo
Lack or loss of appetite (Anorexia)
Pomanjkanje ali izguba apetita (anoreksija)
Lack or loss of strength (weakness).
pomanjkanje ali izguba moči (šibkost),
Lacosamide
lakozamid
Lacosamide (Vimpat) is used to treat a certain form of epilepsy (see below) in patients aged 16 years and older.
Lakozamid (zdravilo Vimpat) se uporablja za zdravljenje določene oblike epilepsije (glejte spodaj) pri bolnikih, starih 16 let in več.
Lacosamide did not affect the AUC of midazolam (metabolised by CYP3A4, lacosamide given 200 mg twice daily) but Cmax of midazolam was slightly increased (30%).
Lakozamid ni vplival na AUC midazolama (ki se metabolizira s CYP3A4, odmerek lakozamida 200 mg dvakrat na dan), nekoliko pa se je povečala Cmax midazolama (30 %).
Lacosamide did not affect the AUC of midazolam (metabolised by CYP3A4, lacosamide given 200 mg twice daily.) but Cmax of midazolam was slightly increased (30%).
Lakozamid ni vplival na AUC midazolama (ki se metabolizira s CYP3A4, odmerek lakozamida 200 mg dvakrat na dan), nekoliko pa se je povečala Cmax midazolama (30 %).
Lacosamide did not affect the pharmacokinetics of omeprazole (metabolised by CYP2C19 and 3A4, lacosamide given 300 mg twice daily).
Lakozamid ni vplival na farmakokinetiko omeprazola (ki se metabolizira s CYP2C19 in 3A4, odmerek lakozamida 300 mg dvakrat na dan).
Lacosamide did not affect the pharmacokinetics of omeprazole (metabolised by CYP2C19 and 3A4, lacosamide given 300 mg twice daiy).
Lakozamid ni vplival na farmakokinetiko omeprazola (ki se metabolizira s CYP2C19 in 3A4, odmerek lakozamida 300 mg dvakrat na dan).
Lacosamide does not inhibit or induce CYP2C19 and 3A4 to a clinically relevant extent.
Lakozamid ne zavira in ne inducira CYP2C19 in CYP3A4 v klinično pomembnem obsegu.
Lacosamide has minor to moderate influence on the ability to drive and use machines.
Lakozamid ima blag ali zmeren vpliv na sposobnost vožnje in upravljanja s stroji.
Lacosamide is also thought to be involved in the development of nerve cells that have been damaged.
Lakozamid naj bi tudi vplival na razvoj živčnih celic, ki so bile poškodovane.
Lacosamide is less than 15% bound to plasma proteins.
Na plazemske beljakovine se veže manj kot 15 % lakozamida.
Lacosamide must be administered twice a day (usually once in the morning and once in the evening).
Lakozamid mora bolnik vzeti dvakrat na dan (običajno enkrat zjutraj in enkrat zvečer).
Lacosamide protected against seizures in a broad range of animal models of partial and primary generalized seizures and delayed kindling development.
Na širokem spektru živalskih modelov s parcialnimi in primarno generaliziranimi napadi so pokazali, da lakozamid varuje pred epileptičnimi napadi in zakasni razvoj epileptogenih sprememb.
Lacosamide should be used with caution in patients with known conduction problems or severe cardiac disease such as a history of myocardial infarction or heart failure.
Lakozamid je treba uporabljati previdno pri bolnikih z motnjami prevodnosti ali pri bolnikih z resnimi srčnimi obolenji, kot sta miokardni infarkt v anamnezi ali srčno popuščanje.
Lacosamide therapy can be initiated with either oral or i.v. administration.
Zdravljenje z lakozamidom lahko začnemo s peroralno ali z intravensko aplikacijo.
Lacosamide treatment has been associated with dizziness or blurred vision.
Zdravljenje z lakozamidom lahko povzroči omotico ali zamegljen vid.
Lacosamide treatment may also be initiated with a single loading dose of 200 mg, followed approximately 12 hours later by a 100 mg twice daily (200 mg/day) maintenance dose regimen.
Zdravljenje z lakozamidom lahko začnemo tudi z enkratnim začetnim (polnilnim) odmerkom 200 mg, ki mu po približno 12 urah sledi vzdrževalni režim odmerjanja 100 mg dvakrat na dan (200 mg/dan).
Lacosomide does not inhibit or induce CYP2C19 and CYP3A4 to a clinically relevant extent.
Lakozamid ne zavira in ne inducira CYP2C19 in CYP3A4 v klinično pomembnem obsegu.
Lacrimal disorder includes adverse reactions of increased lacrimation, dry eye, and acquired dacryostenosis;
Lakrimalne motnje vključujejo neželene učinke, ki se nanašajo na povečano solzenje, suhe oči in pridobljeno dakriostenozo.
Lacrimal duct stenosis
tenoza solznega
Lacrimal duct stenosis (rare), Corneal disorders (rare), keratitis (rare), punctate
stenoza solznega voda (redki), bolezni roženice (redki), keratitis (redki), keratitis punctata (redki)
Lacrimal duct stenosis (rare), Corneal disorders (rare), keratitis (rare), punctate keratitis (rare)
stenoza solznega voda (redki), bolezni roženice (redki), keratitis (redki), keratitis punctata (redki)
Lacrimal duct stenosis (rare), Corneal disorders(rare), keratitis (rare), punctate keratitis
stenoza solznega voda (redki), bolezni roženice (redki), keratitis (redki), keratitis punctata (redki)
Lacrimal duct stenosis (rare), Corneal disorders(rare), keratitis (rare), punctate keratitis (rare)
stenoza solznega voda (redki), bolezni roženice (redki), keratitis (redki), keratitis punctata (redki)
Lacrimal duct stenosis (rare), Corneal disorders(rare), keratitis (rare), punctate keratitis (rare)
tenoza solznega voda (redki), bolezni roženice (redki), keratitis (redki), keratitis punctata (redki)
Lacrimation
motnje
Lacrimation
motnje solzenja***,
Lacrimation
nearteritična
Lacrimation
povečano solzenje,
lacrimation disorder, conjunctivitis
motnje solzenja, konjunktivitis
Lacrimation disorders***, Eye pain, Photophobia, Photopsia, Ocular hyperaemia, Visual brightness, Conjunctivitis
motnje solzenja***, bolečine v očeh, fotofobija, fotopsija, očesna hiperemija,
Lacrimation increased
močnejše solzenje
Lacrimation increased
Močnejše solzenje, konjunktivitis
Lacrimation increased
povečano solzenje
Lacrimation increased (G 3/4; 0.6%)
močnejše solzenje (S 3/4; 0,6 %)
Lacrimation increased (G 3/4; 0.6%)
močnejše solzenje (S3/4; 0,6 %)
Lacrimation increased (G3/4: 0%)
močnejše solzenje (S 3/4: 0 %)
Lacrimation increased (G3/4: 0%)
močnejše solzenje (S3/4: 0 %)
Lacrimation increased (G3/4: 0%).
Močnejše solzenje (S3/4: 0 %)
Lacrimation increased (G3/4: 0.1%);
Faringo-laringealna bolečina (S3/4: 2 %)
Lacrimation increased (G3/4: 0.1%);
Motnja solzenja (S3/4: < 0,1 %)
Lacrimation increased (G3/4: 0.6%)
Močnejše solzenje
Lacrimation increased (G3/4: 0.6%)
močnejše solzenje (S3/4: 0,6 %)
Lacrimation increased (G3/4: 0.6%)
močnejše solzenje (S3/4:0,6 %)
Lacrimation increased (G3/4: 0.6%)
močnejše solzenje (S3/4; 0,6 %)
Lacrimation increased (G3/4: < 0.1%)
motnja solzenja (S3/4: < 0,1 %)
Lacrimation increased (G3/4: <0.1%)
motnja solzenja (S3/4: < 0,1 %)
Lacrimation increased (G3/4: <0.1%)
motnja solzenja (S3/4: < 0,1 %),
Lacrimation increased (G3/4: <0.1%)
povečanje solzenja (S 3/4: 0,1 %)
Lacrimation increased (G3/4: <0.1%)
zvečano solzenje (S 3/4: <0,1 %)
Lacrimation increased (N)
povečano solzenje (N)
Lacrimation increased Conjunctivitis
Močnejše solzenje (S3/4: 0 %)
Lacrimation increased Conjunctivitis
Zvečano solzenje, konjunktivitis
Lacrimation increased, Conjunctivitis, Eye irritation
povečano solzenje, konjunktivitis, vnetje oči
Lacrimation increased; Conjunctivitis
močnejše solzenje, konjunktivitis
Lacrimation increased; Conjunctivitis
zvečano solzenje, konjunktivitis
Lacrimation increased; Conjunctivitis
zvečano solzenje; konjunktivitis
Lacrimation, blurred vision
solzenje, zamegljen vid
Lactated Ringer’s solution
raztopino Ringerjevega laktata
Lactated Ringer’s solution for injection.
Ringerjeva raztopina z laktatom za injiciranje
Lactating rats exposed to Qutenza daily for 3 hours showed measurable levels of capsaicin in the mothers’ milk.
Pri podganah v laktaciji, ki so bile izpostavljene zdravilu Qutenza vsak dan 3 ure, so bile opažene merljive ravni kapsaicina v mleku samic.
Lactation did not influence duloxetine pharmacokinetics
Dojenje ni vplivalo na farmakokinetiko duloksetina.
Lactation.
dojenje;
Lactation:
Komplicirana nevtropenija
Lactation:
Laktacija
Lactic acid Glyceryl triacetate
mlečna kislina gliceriltriacetat
Lactic acidosis (a build-up of lactic acid in the blood).
Laktacidoza (kopičenje mlečne kisline v krvi).
Lactic acidosis (a build-up of lactic acid in the body) is a side effect which may occur in less than 1 in 10,000 patients.
Laktacidoza (kopičenje mlečne kisline v telesu) je neželeni učinek, ki se lahko pojavi pri manj kot 1 bolniku od 10 000.
lactic acidosis (build up of acid in your blood) in some cases involving motor weakness (weakness in your arms, legs or hands)
laktacidoza (zastajanje kisline v krvi), ki v nekaterih primerih vključuje tudi šibkost rok ali nog
Lactic acidosis (excess lactic acid in the blood) is a rare (can affect up to 1 in every
laktacidoza (povečana količina mlečne kisline v krvi) je redek (prizadene lahko do 1 od
Lactic acidosis (excess lactic acid in the blood) is a rare but potentially life-threatening side effect of some HIV medicines.
Laktacidoza (preveč mlečne kisline v krvi) je redek, a življenjsko nevaren neželeni učinek pri nekaterih zdravilih za zdravljenje HIV.
Lactic acidosis (excess lactic acid in the blood) is a rare but potentially life-threatening side effect.
laktacidoza (preveč mlečne kisline v krvi) je redek, a potencialno življenjsko nevaren neželeni učinek.
Lactic acidosis (excess lactic acid in the blood) tingling or numbness of the arms, legs, hands or feet.
laktacidoza (čezmerno kopičenje mlečne kisline v krvi), občutek mravljinčenja ali odrevenelost rok, nog, dlani ali stopal.
Lactic acidosis (sometimes fatal) has been reported in pregnant women who received Zerit in combination with other antiretroviral treatment.
Pri nosečnicah, ki so se zdravile z zdravilom Zerit v kombinaciji z drugimi protiretrovirusnimi zdravili so poročali o pojavu laktacidoze (ki se je v posameznih primerih končala tudi smrtno).
Lactic acidosis (sometimes fatal) has been reported in pregnant women who received Zerit in combination with other antiretroviral treatment.
Pri nosečnicah, ki so se zdravile z zdravilom Zerit v kombinaciji z drugimi protiretrovirusnimi zdravili, so poročali o pojavu laktacidoze (ki se je v posameznih primerih končala tudi smrtno).
Lactic acidosis (very rare, may affect up to 1 in 10,000 people) too much lactic acid in your blood (lactic acidosis).
laktacidoza (zelo redki, pojavijo se lahko pri največ 1 od 10.000 bolnikov) preveč mlečne kisline v krvi (laktacidoza).
Lactic acidosis and worsening liver function are side effects associated with Highly Active Anti-Retroviral Therapy (HAART), an HIV treatment.
Laktacidoza in poslabšanje delovanja jeter sta neželena učinka, ki sta povezana z visoko aktivno protiretrovirusno terapijo (HAART– »Highly Active Anti-Retroviral Therapy«) in zdravljenjem HIV.
Lactic acidosis as a secondary event often associated with serious conditions (e.g. multi- organ failure or sepsis)
laktacidoza kot sekundarni dogodek, ki je pogosto povezan z resnimi stanji (na primer z večorgansko odpovedjo ali s sepso)
Lactic acidosis has a high mortality and may be associated with pancreatitis, liver failure, or renal failure.
Umrljivost zaradi laktacidoze je visoka in je lahko povezana s pankreatitisom, odpovedjo jeter ali odpovedjo ledvic.
Lactic acidosis is a medical emergency and must be treated in a hospital.
Laktacidoza je nujno stanje in jo je treba zdraviti v bolnišnici.
Lactic acidosis is a medical emergency and must be treated in a hospital.
Laktacidoza je nujno zdravstveno stanje, ki ga je treba zdraviti v bolnišnici.
Lactic acidosis is a medical emergency and must be treated in hospital.
Laktacidoza je nujni medicinski primer in jo je treba zdraviti v bolnišnici.
Lactic acidosis is a medical emergency and must be treated in hospital.
Laktacidoza je nujno zdravstveno stanje in jo je treba zdraviti v bolnišnici.
Lactic acidosis is a rare but serious side effect
Laktacidoza je redek, vendar resen neželen učinek.
Lactic acidosis is a serious but very rare side effect of taking Hepsera.
Laktoacidoza je resen, vendar zelo redek neželeni učinek pri jemanju zdravila Hepsera.
Lactic acidosis is a very rare but serious metabolic complication that can occur due to metformin accumulation.
Laktacidoza je zelo redek, a resen presnovni zaplet, do katerega lahko pride zaradi kopičenja metformina.
Lactic acidosis is a very rare, but serious (high mortality in the absence of prompt treatment), metabolic complication that can occur due to accumulation of metformin, a component of this medicinal product.
Laktacidoza je zelo redek, vendar resen presnovni zaplet, ki se lahko pojavi zaradi kopičenja metformina (ki je sestavina tega zdravila) in ga brez takojšnjega zdravljenja spremlja velika umrljivost.
Lactic acidosis is a very rare, but serious (high mortality in the absence of prompt treatment), metabolic complication that can occur due to metformin accumulation.
Laktacidoza je zelo redek, vendar resen presnovni zaplet (visoka stopnja smrtnosti, če se zdravljenje ne začne takoj), ki se lahko pojavi zaradi kopičenja metformina.
Lactic acidosis is a very rare, but serious (high mortality in the absence of prompt treatment), metabolic complication that can occur due to metformin, a component of this medicinal product, accumulation.
Laktacidoza je zelo redek, vendar resen presnovni zaplet (brez takojšnjega zdravljenja ga spremlja velika umrljivost), ki se lahko pojavi zaradi kopičenja metformina (učinkovina v tem zdravilu).
Lactic acidosis is a very rare, but serious (high mortality rate in the absence of prompt treatment), metabolic complication that can occur due to metformin accumulation.
Laktaacidoza je zelo redek, toda resen presnovni zaplet (zaradi velike umrljivosti, če ni takojšnjega zdravljenja), ki ga lahko povzroči kopičenje metformina.
Lactic acidosis is characterised by acidotic dyspnea, abdominal pain and hypothermia followed by coma.
Značilnosti laktacidoze so acidozna dispneja, trebušna bolečina in hipotermija, ki ji sledi koma.
Lactic acidosis is characterised by acidotic dyspnoea, abdominal pain and hypothermia followed by coma.
Za laktacidozo so značilne acidotična dispneja, bolečine v trebuhu in hipotermija, ki ji sledi koma.
Lactic acidosis is further characterised by acidotic dyspnoea and hypothermia followed by coma.
Za laktacidozo sta nadalje značilni še acidozna dispneja in hipotermija, ki jima sledi koma.
Lactic acidosis is more likely to develop in people who have liver disease, or in obese (very overweight) people, especially women.
Nastanek laktacidoze je verjetnejši pri osebah, ki imajo bolezen jeter ali so debele (z močno prekomerno telesno maso), zlasti pri ženskah.
Lactic acidosis is more likely to happen in people who have liver problems, or in people who are very overweight, especially women.
Laktacidoza je verjetnejša pri bolnikih, ki imajo težave z jetri, ali tistih z močno prekomerno telesno maso, zlasti pri ženskah.
Lactic acidosis occurs more often in women – particularly if they are overweight and in people with liver disease.
Laktacidoza se pogosteje pojavi pri ženskah, zlasti tistih s prekomerno telesno maso in pri ljudeh z jetrno boleznijo.
Lactic acidosis occurs more often in women – particularly if they are overweight, and in people with liver disease.
Laktacidoza se pogosteje pojavi pri ženskah, zlasti tistih s prekomerno telesno maso in pri ljudeh z jetrno boleznijo.
Lactic acidosis occurs more often in women, particularly if they are very overweight.
Do laktacidoze pride pogosteje pri ženskah, še posebno če imajo preveliko telesno težo.
Lactic acidosis, Vitamin B12 deficiencya
laktacidoza, pomanjkanje vitamina B a
Lactic acidosis: 0.03 cases/1000 patient-years (see section 4.4).
Laktacidoza: 0,03 primera/1.000 bolnikov-let (glejte poglavje 4.4).
Lactobacillus, Leuconostoc and Pediococcus that are intrinsically resistant to glycopeptides.
Lactobacillus, Leuconostoc in Pediococcus, ki so intrinzično odporni na glikopeptide.
Lactose
564 (242)
Lactose
Laktoza.
Lactose (as monohydrate) Microcrystalline cellulose Croscarmellose sodium Hydroxypropyl cellulose Silicon dioxide
laktoza (v obliki laktoze monohidrata) mikrokristalna celuloza
Lactose (monohydrate), Magnesium stearate.
mikrokristalna celuloza, premreženi natrijev karmelozat, povidon, laktoza (monohidrat), magnezijev stearat.
Lactose (one type of sugar).
laktozo (vrsta sladkorja).
Lactose anhydrous Microcrystalline cellulose Croscarmellose sodium Silica, colloidal anhydrous Magnesium stearate Tablet coating:
brezvodna laktoza mikrokristalna celuloza premrežen natrijev karmelozat
Lactose anhydrous Microcrystalline cellulose Hydroxypropylcellulose Croscarmellose sodium Magnesium stearate
brezvodna laktoza mikrokristalna celuloza hidroksipropilceluloza premrežen natrijev karmelozat magnezijev stearat
Lactose intolerance: Invirase 200 mg capsules contain lactose.
Intoleranca za laktozo: kapsule Invirase 200 mg vsebujejo laktozo.
Lactose monohydrate
laktoza monohidrat
Lactose monohydrate (see section 2)
laktoza monohidrat (glejte poglavje 2)
Lactose monohydrate Anise aroma powder Silica colloidal hydrated.
laktoza monohidrat prašek z aromo janeža silicijev dioksid, koloidni, hidratirani
Lactose monohydrate Cellulose microcrystalline Hypromellose Magnesium stearate Sodium starch glycolate
laktoza, monohidrat celuloza, mikrokristalna hipromeloza magnezijev stearat natrijev karboksimetilškrob
Lactose monohydrate Cellulose, microcrystalline Crospovidone
Laktoza monohidrat Celuloza, mikrokristalna Krospovidon
Lactose monohydrate Cellulose, microcrystalline Maize starch Hydroxypropylcellulose Magnesium stearate
laktoza monohidrat mikrokristalna celuloza koruzni škrob hidroksipropilceluloza magnezijev stearat indigotin (E 132)
Lactose monohydrate Cellulose, microcrystalline Povidone
laktoza monohidrat mikrokristalna celuloza povidon
Lactose monohydrate Cellulose, microcrystalline Povidone K30
Laktoza monohidrat Celuloza, mikrokristalna Povidon K30
Lactose monohydrate Crospovidone type A Cellulose, microcrystalline Povidone
laktoza monohidrat krospovidon tipa A mikrokristalna celuloza povidon
Lactose monohydrate Hydroxypropylcellulose (E463) Croscarmellose sodium Magnesium stearate (E572)
laktoza monohidrat hidroksipropilceluloza (E463) premreženi natrijev karmelozat magnezijev stearat (E572)
Lactose monohydrate Hypromellose (E464) Titanium dioxide (E171) Iron oxide yellow (E172) Triacetin
Filmska obloga: laktoza monohidrat hipromeloza (E464) titanov dioksid (E171) rumeni železov oksid (E172) triacetin
Lactose monohydrate Hypromellose (E464) Titanium dioxide (E171) Triacetin (E1518) Yellow iron oxide (E172)
Filmska obloga: laktoza monohidrat hipromeloza (E464) titanov dioksid (E171) triacetin (E1518) rumeni železov oksid (E172)
lactose monohydrate hypromellose triacetin titanium dioxide (E171) iron oxide yellow (E172) iron oxide red (E172) talc
Filmska obloga laktoza monohidrat hipromeloza triacetin titanov dioksid (E171) rumeni železov oksid (E172) rdeči železov oksid (E172) smukec
Lactose monohydrate Macrogol 4000 Hypromellose (E464) Titanium dioxide E171
Laktoza monohidrat Makrogol 4000 Hipromeloza (E464) Titanov dioksid (E171)
Lactose monohydrate Macrogol Magnesium stearate Talc
laktoza monohidrat, makrogol, magnezijev stearat, smukec.
Lactose monohydrate Magnesium stearate
laktoza monohidrat magnezijev stearat
Lactose monohydrate Magnesium stearate
natrijev karmelozat, premreženi laktoza monohidrat magnezijev stearat
Lactose monohydrate Maize starch Hypromellose Polysorbate 20 Microcrystalline cellulose Croscarmellose sodium
laktoza monohidrat koruzni škrob hipromeloza polisorbat 20
Lactose monohydrate Maize starch Microcrystalline cellulose Hydroxypropyl cellulose Magnesium stearate
laktoza monohidrat koruzni škrob mikrokristalna celuloza hidroksipropilceluloza magnezijev stearat
Lactose monohydrate Maize starch Microcrystalline cellulose Hydroxypropyl cellulose Magnesium stearate Yellow iron oxide (E172)
laktoza monohidrat koruzni škrob mikrokristalna celuloza hidroksipropilceluloza magnezijev stearat rumen železov oksid (E172)
lactose monohydrate maize starch microcrystalline cellulose sodium starch glycolate (Type A) hydroxypropylcellulose magnesium stearate
mikrokristalna celuloza natrijev karboksimetilškrob (vrsta A) hidroksipropilceluloza magnezijev stearat
Lactose monohydrate Microcristalline cellulose Artificial meat flavour Crospovidone
laktoza monohidrat celuloza, mikrokristalna umetna mesna aroma krospovidon
Lactose monohydrate Microcrystalline cellulose (E460) Croscarmellose sodium (E468) Magnesium stearate (E470b)
Mikrokristalna celuloza (E460) Premreženi natrijev karmelozat (E468) Magnezijev stearat (E470b)
Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Colloidal anhydrous silica Magnesium stearate
laktoza monohidrat mikrokristalna celuloza premrežen natrijev karmelozat koloidni brezvodni silicijev dioksid magnezijev stearat
Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Povidone K25 Magnesium stearate Colloidal silica
mikrokristalna celuloza natrijev karmelozat, premreženi povidon K25 magnezijev stearat koloidni silicijev dioksid
Lactose monohydrate Microcrystalline cellulose Hydroxypropylcellulose Croscarmellose sodium Colloidal anhydrous silica Magnesium stearate
mikrokristalna celuloza hidroksipropilceluloza premreženi natrijev karmelozat koloidni brezvodni silicijev dioksid magnezijev stearat